The Philippine Competition Commission (PCC) said it released the guidelines on merger remedies, a comprehensive framework outlining the approach to assessing and implementing remedies in merger and acquisition (M&A) transactions.
The guidelines aim to ensure that mergers do not harm competition and ultimately protect consumer welfare.
Approved by the PCC on May 9, 2024, the guidelines offer detailed guidance on the design, selection and implementation of remedies.
The PCC said each M&A transaction requires a tailored assessment and that remedies must be effective, proportionate, and address the specific competition concerns identified.
The guidelines provide that remedies should directly address identified competition concerns and be proportional to the identified anti-competitive effects.
The PCC’s merger review mandate aims to safeguard competition in the market after an M&A is completed, ensuring that consumers continue to benefit from a variety of choices and fair prices.
